Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.

Authors:
Address: Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Journal:


Publication:
Free Text: Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.

abstract

BACKGROUND:

Ebolavirus belongs to the family filoviridae and causes severe hemorrhagic fever in humans with 50-90% lethality. Detailed understanding of how the viruses attach to and enter new host cells is critical to development of medical interventions. The virus displays a trimeric glycoprotein (GP(1,2)) on its surface that is solely responsible for membrane attachment, virus internalization and fusion. GP(1,2) is expressed as a single peptide and is cleaved by furin in the host cells to yield two disulphide-linked fragments termed GP1 and GP2 that remain associated in a GP(1,2) trimeric, viral surface spike. After entry into host endosomes, GP(1,2) is enzymatically cleaved by endosomal cathepsins B and L, a necessary step in infection. However, the functional effects of the cleavage on the glycoprotein are unknown.

PRINCIPAL FINDINGS:

We demonstrate by antibody binding and Hydrogen-Deuterium Exchange Mass Spectrometry (DXMS) of glycoproteins from two different ebolaviruses that although enzymatic priming of GP(1,2) is required for fusion, the priming itself does not initiate the required conformational changes in the ectodomain of GP(1,2). Further, ELISA binding data of primed GP(1,2) to conformational antibody KZ52 suggests that the low pH inside the endosomes also does not trigger dissociation of GP1 from GP2 to effect membrane fusion.

SIGNIFICANCE:

The results reveal that the ebolavirus GP(1,2) ectodomain remains in the prefusion conformation upon enzymatic cleavage in low pH and removal of the glycan cap. The results also suggest that an additional endosomal trigger is necessary to induce the conformational changes in GP(1,2) and effect fusion. Identification of this trigger will provide further mechanistic insights into ebolavirus infection.



Related Articles
Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.
J Virol. 2012
Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.
Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, White JM. J Virol. 2012 Jan; 86(1):364-72. Epub 2011 Oct 26.
Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2.
Proc Natl Acad Sci U S A. 2011
Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2.
Gregory SM, Harada E, Liang B, Delos SE, White JM, Tamm LK. Proc Natl Acad Sci U S A. 2011 Jul 5; 108(27):11211-6. Epub 2011 Jun 20.
Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
J Virol. 2010
Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.
Hood CL, Abraham J, Boyington JC, Leung K, Kwong PD, Nabel GJ. J Virol. 2010 Mar; 84(6):2972-82. Epub 2010 Jan 6.
Review Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.
Curr Opin Struct Biol. 2009
Review Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.
Lee JE, Saphire EO. Curr Opin Struct Biol. 2009 Aug; 19(4):408-17. Epub 2009 Jun 24.
Review Structural basis for membrane fusion by enveloped viruses.
Mol Membr Biol. 1999
Review Structural basis for membrane fusion by enveloped viruses.
Weissenhorn W, Dessen A, Calder LJ, Harrison SC, Skehel JJ, Wiley DC. Mol Membr Biol. 1999 Jan-Mar; 16(1):3-9.
Structural basis for differential neutralization of ebolaviruses.
Viruses. 2012
Structural basis for differential neutralization of ebolaviruses.
Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, Liu T, Keuhne AI, Li S, Woods VL Jr, Chandran K, et al. Viruses. 2012 Apr; 4(4):447-70. Epub 2012 Apr 5.
The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
PLoS Pathog. 2012
The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold.
Zhang AP, Bornholdt ZA, Liu T, Abelson DM, Lee DE, Li S, Woods VL Jr, Saphire EO. PLoS Pathog. 2012 Feb; 8(2):e1002550. Epub 2012 Feb 23.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.